01 / Vendor Profile
SANOFI VACCINES US INC. Federal Contracts and Awards
UEI NCXBGGQ8YTU9 · CAGE 7V915
Federal contract activity attributed to this vendor identity across FY 2020–FY 2026. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2020–FY 2026.
Across FY 2020–FY 2026, FPDS records attribute $266.47M in net contract obligations to SANOFI VACCINES US INC. across 909 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
SANOFI VACCINES US INC. contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations$31.89M
FY 2026ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2020 | $18.40M | 123 | 12 | — |
| FY 2021 | $3.74M | 85 | 11 | −79.7% |
| FY 2022 | $27.23M | 78 | 11 | +628.2% |
| FY 2023 | $53.44M | 177 | 10 | +96.3% |
| FY 2024 | $59.09M | 192 | 12 | +10.6% |
| FY 2025 | $72.68M | 87 | 9 | +23.0% |
| FY 2026 | $31.89M | 167 | 12 | −56.1% |
04 / Federal Customers
Which federal agencies buy from SANOFI VACCINES US INC.?
Ranked by net obligations during FY 2020–FY 2026.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 7505 | $167.44M | 107 | 62.8% | |
| 97AS | $42.75M | 148 | 16.0% | |
| 3600 | $25.64M | 143 | 9.6% | |
| 7527 | $21.12M | 33 | 7.9% | |
| 1900 | $3.75M | 50 | 1.4% | |
| 1549 | $1.87M | 30 | 0.7% | |
| 1540 | $1.44M | 298 | 0.5% | |
| 7523 | $1.11M | 49 | 0.4% | |
| 7570 | $501.6K | 23 | 0.2% | |
| 7529 | $405.8K | 10 | 0.2% |
05 / Contracting Offices
Which contracting offices buy from SANOFI VACCINES US INC.?
Ranked by net obligations during FY 2020–FY 2026.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 75A501 | ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE | $167.44M | 107 | 62.8% | |
| SPE2DP | DEFENSE LOGISTICS AGENCY | $42.75M | 148 | 16.0% | |
| 75H711 | INDIAN HEALTH SERVICE | $22.24M | 26 | 8.3% | |
| 36C261 | VETERANS AFFAIRS, DEPARTMENT OF | $7.59M | 47 | 2.8% | |
| 36C260 | VETERANS AFFAIRS, DEPARTMENT OF | $4.87M | 22 | 1.8% | |
| 36C246 | VETERANS AFFAIRS, DEPARTMENT OF | $4.11M | 19 | 1.5% | |
| 36C245 | VETERANS AFFAIRS, DEPARTMENT OF | $3.88M | 25 | 1.5% | |
| 19AQMM | STATE, DEPARTMENT OF | $3.06M | 13 | 1.1% | |
| 36C252 | VETERANS AFFAIRS, DEPARTMENT OF | $1.89M | 8 | 0.7% | |
| 15F067 | FEDERAL BUREAU OF INVESTIGATION | $1.87M | 30 | 0.7% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 325412 | PHARMACEUTICAL PREPARATION MANUFACTURING | $105.19M | 638 | 13 | 39.5% |
| 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | $82.57M | 137 | 7 | 31.0% |
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $74.98M | 47 | 1 | 28.1% |
| 493120 | REFRIGERATED WAREHOUSING AND STORAGE | $1.64M | 22 | 1 | 0.6% |
| 339112 | SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING | $1.25M | 2 | 1 | 0.5% |
| 423450 | MEDICAL, DENTAL, AND HOSPITAL EQUIPMENT AND SUPPLIES MERCHANT WHOLESALERS | $690.4K | 38 | 2 | 0.3% |
| 325411 | MEDICINAL AND BOTANICAL MANUFACTURING | $183.7K | 16 | 2 | 0.1% |
| 541940 | VETERINARY SERVICES | $47.6K | 1 | 1 | 0.0% |
| 424210 | DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS | $4.0K | 4 | 2 | 0.0% |
| 333914 | MEASURING, DISPENSING, AND OTHER PUMPING EQUIPMENT MANUFACTURING | $3.3K | 3 | 1 | 0.0% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| Q999 | MEDICAL- OTHER | $101.61M | 28 | 2 | 38.1% |
| 6505 | DRUGS AND BIOLOGICALS | $101.38M | 702 | 13 | 38.0% |
| AN12 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $74.98M | 47 | 1 | 28.1% |
| R799 | SUPPORT- MANAGEMENT: OTHER | $1.64M | 22 | 1 | 0.6% |
| 6515 | MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $1.46M | 61 | 6 | 0.5% |
| 6525 | IMAGING EQUIPMENT AND SUPPLIES: MEDICAL, DENTAL, VETERINARY | $138.2K | 7 | 1 | 0.1% |
| Q517 | MEDICAL- PHARMACOLOGY | $88.4K | 17 | 1 | 0.0% |
| Q201 | MEDICAL- GENERAL HEALTH CARE | $41.6K | 14 | 1 | 0.0% |
| 3650 | CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $23.1K | 4 | 1 | 0.0% |
| 6640 | LABORATORY EQUIPMENT AND SUPPLIES | -$1.0K | 4 | 2 | 0.0% |
08 / Competition Pattern
How was SANOFI VACCINES US INC.’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for SANOFI VACCINES US INC.?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 75A50126F61014 | Sep 21, 2026 | $6.02M | ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE BARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | AN12 |
10 / Interpreting the Profile
How should you evaluate SANOFI VACCINES US INC. as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.